Navigation Links
Study of 137 Meniscus Transplant Procedures in Patients with Arthritis is Presented to the Meniscus Transplantation Study Group at the American Academy of Orthopaedic Surgeons Annual Meeting
Date:3/6/2008

Follow-Up Study Supports Biologic Joint Reconstruction Rather Than

Artificial Total Knee Replacement

SAN FRANCISCO, March 6 /PRNewswire/ -- In a report to the meeting of the Meniscus Transplantation Study Group, presented during the 2008 meeting of the American Academy of Orthopaedic Surgeons, Kevin R. Stone, M.D., of the Stone Research Foundation, San Francisco, presented an update on the outcome of 137 patients with arthritis who have undergone allograft replacement procedures of the meniscus since 1997.

In the follow-up study of objective clinical evaluation and imaging of the knee and the patients' subjective evaluation, 111 patients experienced successful outcomes after periods ranging from three months to 10.5 years. The failure rate was 19% with a mean time to failure of 4.79 years.

The allograft replacement procedure replaces the meniscus with a donor allograft. The procedure, which is used to protect the articular cartilage and/or reduce pain, is performed on an outpatient basis and is done arthroscopically and is, therefore, minimally invasive.

"The importance of this study," according to Dr. Stone, "is that it documents that meniscus replacement is an excellent option for some patients facing artificial total knee replacement. It can reduce patient pain and also delay the necessity for total replacement."

"The study also showed," he said, "that meniscal allograft transplantation is a viable treatment option for arthritic patients of all ages."

Among the unexpected study results was the variation in the objective and subjective evaluations of the procedure's success. In some cases, patients reported reduced or no pain when the objective evaluation and imaging seemed to indicate significant arthritis.

"Thus, subjective patient outcomes are critical in evaluating the success of the procedure," said Dr. Stone.

About The Stone Research Foundation

The Stone Research Foundation engages in research, development and education to prevent, treat and reverse arthritis and joint injuries. Its goal is to find minimally invasive biologic joint replacement treatments. It seeks to harness natural healing and regenerative capacities to reconstruct joints damaged by arthritis and injury. The Stone Research Foundation is a non-profit 501( c )3 organization (Tax I.D. # 94-3228007).

For more information, please contact:

Stephanie Stern, Stern & Co. at 212 888-0044


'/>"/>
SOURCE Stone Research Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New study sheds light on excessive drinking among the elderly
2. When it comes to emotions, Eastern and Western cultures see things very differently: Study
3. Aromatherapy Falls Short, Study Finds
4. New Study: Aging Baby Boomers Could Overwhelm U.S. Health Care System by 2017, Unless Decisive Action Is Taken
5. Carnegie Mellon study shows just listening to cell phones significantly impairs drivers
6. Southgate Community Schools To Present Studywiz Spark at Michigan Computer Users in Learning (MACUL) Conference
7. WHI follow-up study: Risks of long-term hormone therapy continue to outweigh benefits
8. Diamonds Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers Health and Wealth Needs
9. Study shows cholesterol-lowering power of dietitian visits
10. Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study
11. Genome-wide association study on Parkinsons disease finds public home at NIH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... ... January 22, 2017 , ... Zifam Pinnacle, an Australian company ... recently met with big-name retail buyers at the January ECRM Trade Show in Hilton ... uses the utmost safety standards in all of its creations to help create a ...
(Date:1/22/2017)... ... January 22, 2017 , ... Medical lab testing through hospitals and ... a simple test will take days to arrive to the end customer, having to ... access to their lab tests, bypassing the cost and delay of traditional means. Now ...
(Date:1/21/2017)... ... January 21, 2017 , ... Salveo for life, a company that ... product to the United States as part of its presence to expand its market ... aims to reduce the productions of nasty toxins as a result of drinking alcohol, ...
(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at global business ... recognized globally as one of the healthiest cereals, XieQingkui, the founder of Seamild, strongly ... to sow the seed of good karma. Buddhism spirit featuring benevolence and sacrifice are ...
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate Institute’s Alumni ... line-up of events for its annual meeting “Coming Home 2017,” an activity-packed weekend ... Home 2017” will be held on Friday January 27 through Sunday, January 29, ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... , January 23, 2017 Stock-Callers.com ... Pharmaceuticals Inc. (NASDAQ: CPRX ), Sophiris Bio Inc. ... MNTA ), and Agile Therapeutics Inc. (NASDAQ: ... which turned somewhat lower in late trade on Friday, January ... dropping about 0.3%, while shares of health care companies in ...
(Date:1/23/2017)... , 23. Januar 2017  ResMed (NYSE: ... und 3B Medical ( Winter Haven, Florida ... Vereinbarung über die Beilegung aller globalen Rechtsstreitigkeiten zwischen den ... Verkauf ihrer bestehenden Produkte im Tausch gegen Lizenzgebühren ... an 3B leisten, um das in Florida ...
(Date:1/22/2017)... ABU DHABI , Saudi Arabia , January 22, 2017 ... the US and UAE ... Future , at the World Economic Forum   ... be driven by big data and powered by artificial intelligence and this trend ... that discussed the ,Hospital of the Future, at the concluding day of the ...
Breaking Medicine Technology: